BrainTrip is a Malta-based startup offering fast and affordable dementia screening for the mass market. Leveraging an electroencephalogram (EEG) based algorithm, the company has developed a reliable method for detecting mental impairment, particularly early-stage dementia, in individuals over 60. This non-invasive screening tool is especially valuable in elderly care facilities, providing a cost-effective and quick alternative to the expensive and invasive medical workups traditionally used for dementia diagnosis.
Founded in 2019, BrainTrip's innovative approach to dementia screening has attracted the attention of Fast Track Malmo, who provided non-equity assistance investment in March 2020. With its potential to make a significant impact in the health care industry, BrainTrip presents a compelling opportunity for investors looking to support breakthrough solutions in dementia diagnosis and elderly care.
No recent news or press coverage available for BrainTrip.